{"gene":"DNTT","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1993,"finding":"TdT is responsible for template-independent N-region nucleotide addition at V(D)J gene segment junctions. TdT-deficient mice completely lack N regions in immunoglobulin and T cell receptor variable region genes, proving TdT is the enzyme responsible for junctional diversity.","method":"Genetic knockout (TdT-deficient mice), sequence analysis of V(D)J junctions","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent labs published simultaneously using TdT knockout mice with direct sequencing of receptor genes, replicated across studies","pmids":["8356451","8356452"],"is_preprint":false},{"year":1993,"finding":"TdT expression in adult mice blocks homology-directed (P-nucleotide/microhomology) V(D)J recombination; TdT-deficient adult mice show extensive homology-directed recombination, indicating TdT's N-addition activity suppresses this alternative joining pathway.","method":"Genetic knockout (TdT-deficient mice), sequence analysis of V(D)J junctions","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — demonstrated in TdT knockout mouse model with direct sequence evidence, replicated independently","pmids":["8356452","8356451"],"is_preprint":false},{"year":1995,"finding":"Forced TdT expression (via CD2-promoter transgene) in fetal thymus V gamma 3+ T cells markedly reduces the frequency of canonical invariant TCR gamma-delta junctions and increases non-canonical junctions with N nucleotides, demonstrating TdT activity directly inhibits junctional homogeneity in fetal thymocytes.","method":"Transgenic mouse overexpression of TdT, analysis of TCR gamma-delta junctions","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Moderate — transgenic gain-of-function with direct sequence readout, single lab with clear phenotypic result","pmids":["7584135"],"is_preprint":false},{"year":1987,"finding":"TdT catalysis is strongly inhibited by Ap5A (P1,P5-bis(5'-adenosyl) pentaphosphate) through interaction at both the dNTP substrate binding domain and the DNA primer binding domain; kinetic analysis showed competitive inhibition at both sites with a Ki ~0.25 µM when both domains are available.","method":"In vitro enzyme kinetics, UV cross-linking of substrate/primer to TdT, borohydride reduction trapping with oxidized Ap5A","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted in vitro biochemical assay with multiple orthogonal methods (kinetics, crosslinking, covalent trapping), single lab","pmids":["2439117"],"is_preprint":false},{"year":2001,"finding":"Ikaros protein dimers compete with an Ets transcription factor activator for occupancy of the TdT promoter to repress TdT transcription during CD4+CD8+ thymocyte differentiation. Mutations that selectively disrupt Ikaros binding to the integrated TdT promoter abolish down-regulation upon differentiation. Chromatin alterations accompany Ikaros-mediated TdT repression, preceding pericentromeric repositioning.","method":"Binding/competition assays, promoter mutagenesis in integrated TdT reporter, chromatin accessibility (restriction enzyme assay), differentiation of CD4+CD8+ thymocyte line","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (competition binding, mutagenesis, chromatin accessibility, differentiation assay), single lab","pmids":["11459831"],"is_preprint":false},{"year":1996,"finding":"E47 (E2A protein) activates the endogenous chromosomal TdT gene when overexpressed in non-B (fibroblast) cells, demonstrating TdT is a direct transcriptional target of E2A proteins early in B-cell lineage commitment.","method":"Stable transfection/overexpression of E47, measurement of endogenous TdT transcription","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — stable cell line overexpression with endogenous gene readout, single lab, single method","pmids":["8890174"],"is_preprint":false},{"year":1995,"finding":"c-Myc/Myn (Max) protein complex binds to the TdT initiator element (InrTdT) at the transcription initiation site, and c-Myc overexpression represses transcriptional activity of the TdT initiator in co-transfection assays.","method":"Gel retardation (EMSA), co-transfection/reporter assay, supershift with specific antibodies","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — EMSA with antibody confirmation plus functional reporter assay, single lab","pmids":["7870572"],"is_preprint":false},{"year":2006,"finding":"TReP-132 directly binds TdT through TdT's N-terminal region and reduces TdT activity to 2.5% of maximum in vitro. TReP-132 also binds TdIF1, and all three proteins co-localize in the nucleus, suggesting TReP-132 negatively regulates TdT during V(D)J recombination.","method":"Yeast two-hybrid, pull-down assay, immunoprecipitation, in vitro TdT activity assay, co-localization by immunofluorescence in COS7 cells","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid confirmed by pull-down and co-IP plus in vitro activity assay, single lab, multiple orthogonal methods","pmids":["16371131"],"is_preprint":false},{"year":2007,"finding":"TdIF1 (TdT-interacting factor 1) binds to the Pol beta-like region in TdT and blocks TdT access to DNA ends, thereby inhibiting TdT activity. In the presence of double-stranded DNA, TdIF1 binds dsDNA through AT-hook-like motif and helix-turn-helix motif, releasing TdT to concentrate near AT-rich DNA for synthesis. Functional domains in TdIF1 include TdT-binding, DNA-binding (three regions), dimerization, and a bipartite NLS overlapping the AT-hook-like motif.","method":"Bioinformatics domain analysis, binding assays (pull-down, co-IP), in vitro TdT activity assays with dsDNA primer","journal":"Genes to cells","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — in vitro activity assay plus binding assays, single lab, multiple orthogonal methods","pmids":["17663723"],"is_preprint":false},{"year":2014,"finding":"CK2 (Casein Kinase II) phosphorylation of Ikaros decreases Ikaros binding to the TdT promoter and reduces Ikaros-mediated transcriptional repression of TdT in thymocytes and T-cell leukemia. PP1 (Protein Phosphatase 1) activity restores Ikaros DNA-binding affinity at the TdT promoter and Ikaros-mediated TdT repression. CK2 inhibition also restores TdT repression.","method":"Ikaros phosphomimetic/phosphoresistant mutants, CK2 and PP1 inhibitors, quantitative ChIP (qChIP), qRT-PCR in primary thymocytes and leukemia cells","journal":"Pediatric blood & cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple mutants plus pharmacological inhibitors with orthogonal chromatin and transcript readouts, single lab","pmids":["25214003"],"is_preprint":false},{"year":2019,"finding":"TdT primes replication slippage at NPM1 to generate AML-associated 4-bp insertion mutations through N-nucleotide addition. Analysis of 2430 NPM1 mutations showed G/C-rich N-nucleotide tracts with polypurine/polypyrimidine stacking bias consistent with TdT synthesis; the TdT-mutator model predicted the relative incidence of 256 potential 4-bp insertions with significant correlation (ρ=0.484). Higher TdT activity in pediatric myeloid cells correlates with longer N-regions in pediatric vs. adult NPM1 mutations.","method":"Large-scale mutational analysis (2430 mutations), statistical modeling, comparison of pediatric vs. adult mutation spectra","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — large-scale sequence analysis with predictive modeling, single study but very large dataset with statistical validation; no direct in vitro reconstitution","pmids":["31650162"],"is_preprint":false},{"year":1988,"finding":"TdT mediates selective cytotoxicity of 2',3'-dideoxyadenosine (ddA) in TdT-positive cells by chain-terminating addition of ddAMP to DNA. A pre-B cell line rendered TdT-positive by retroviral TdT cDNA transduction showed 90% cell death vs. 30% in the TdT-negative parental line under ddA/coformycin treatment, directly demonstrating TdT's role in ddA cytotoxicity.","method":"Retroviral TdT cDNA transduction of TdT-negative cell line, cell viability assay with ddA/CF treatment","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isogenic cell line pair (TdT+/− by retroviral transduction) with direct cytotoxicity comparison, single lab","pmids":["2836001"],"is_preprint":false},{"year":1996,"finding":"Phosphorylation of recombinant TdT by protein kinase A (PKA) dramatically increases its endonuclease activity on supercoiled plasmid DNA in cell-free experiments, converting it to a linearizing endonuclease.","method":"In vitro phosphorylation of recombinant TdT by PKA, endonuclease assay on supercoiled plasmid DNA","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reconstitution with recombinant enzyme plus kinase, single lab, single method, preliminary finding","pmids":["8667637"],"is_preprint":false},{"year":1997,"finding":"TdT has been highly conserved (>70% amino acid similarity) across vertebrate evolution (trout, chicken, Xenopus, mouse, human, cattle). Structural alignment with rat DNA polymerase beta supports the hypothesis that TdT and Pol beta evolved from a common ancestral repair polymerase. Four PKC phosphorylation sites are conserved across species, suggesting a role for PKC in TdT regulation.","method":"cDNA cloning and sequencing, Northern blot, RT-PCR, phylogenetic/structural alignment with rat Pol beta crystal structure","journal":"Immunogenetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — evolutionary sequence comparison and expression analysis; PKC site conservation is computational inference without functional validation","pmids":["9271626"],"is_preprint":false},{"year":2004,"finding":"In the Mexican axolotl, two TdT isoforms exist: TdT1 (full-length, with all conserved catalytic motifs) and TdT2 (lacking the first helix-hairpin-helix DNA-binding motif due to 57-amino acid internal deletion). TdT and Pol mu are closely related paralogs that were already present in the common ancestor of jawed vertebrates.","method":"cDNA cloning, sequence analysis, phylogenetic analysis, RT-PCR developmental expression","journal":"Immunogenetics","confidence":"Low","confidence_rationale":"Tier 3 / Weak — sequence/phylogenetic analysis without direct functional validation of each isoform's activity","pmids":["15146297"],"is_preprint":false},{"year":2016,"finding":"In human fetal B-cell precursors, TdT expression is lower than in pediatric bone marrow precursors, correlating with fewer N-nucleotide additions in IGH gene rearrangements. IL7Rα signaling is required for TdT expression: B-cell progenitors from IL7Rα-deficient patients had reduced TdT expression and fewer N-nucleotide additions at Dh-Jh junctions.","method":"Molecular analysis of Ig gene rearrangements, quantitative expression analysis, analysis of IL7Rα-deficient patient samples","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human patient genetic deficiency combined with molecular sequencing analysis, multiple cohorts, single study","pmids":["27658954"],"is_preprint":false},{"year":2022,"finding":"Using TdT reporter and lineage-tracing transgenic mice, transient TdT induction was detected on a newly identified multipotent progenitor (MPP) subset within MPP4 lacking self-renewal but retaining multilineage differentiation potential. Stable and progressive TdT upregulation defined the lymphoid developmental trajectory. TdT+ MPP multipotency was associated with ESAM expression, and ESAM downregulation marked progressive loss of alternative fates along all lineages.","method":"Transgenic reporter mice (TdT reporter and lineage-trace), single-cell CITE-seq, flow cytometry, differentiation assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — newly generated transgenic reporter mice with single-cell multi-omics and functional differentiation assays, single lab but multiple orthogonal methods","pmids":["35354960"],"is_preprint":false},{"year":2021,"finding":"TdT-derived peptides presented on HLA-A*02:01 are recognized by specific TCRs that, when expressed in T cells, eliminate primary ALL cells of both T- and B-cell origin in vitro and in three mouse models of disseminated B-ALL, while sparing normal peripheral T and B cells and myeloid cells in vitro and in humanized mice. This is mechanistically explained by TdT being an intracellular, lymphoid-restricted antigen expressed highly in 80-94% of B- and T-ALLs but only transiently during normal lymphoid differentiation.","method":"TCR identification and engineering, in vitro cytotoxicity assays, three in vivo mouse models of B-ALL, humanized mice for normal cell sparing","journal":"Nature biotechnology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal in vitro and in vivo models with engineered TCR T cells, single lab but multiple experimental systems","pmids":["34873326"],"is_preprint":false},{"year":1995,"finding":"Avian (chicken) TdT is expressed exclusively in the thymus (not bone marrow or bursa of Fabricius), indicating TdT plays a role in N-region addition in chicken T-cell receptor genes but not in immunoglobulin gene diversification in birds.","method":"Northern blot hybridization, RT-PCR of chicken tissues, expression of recombinant chicken TdT in bacteria with specific activity measurement","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — expression localization by Northern blot and RT-PCR combined with recombinant enzyme characterization, single lab","pmids":["7596835"],"is_preprint":false},{"year":2019,"finding":"Downregulation of TdT expression through PNA-mediated splicing modulation (targeting intron 7 splice junctions of TdT pre-mRNA) in Molt-4 cells leads to reduced TdT protein levels, increased apoptosis, and decreased cell survival, establishing TdT as functionally required for survival of TdT-expressing leukemia cells.","method":"Antisense PNA treatment, RT-PCR (splice variant analysis), Western blot (TdT protein level), apoptosis assay, cell viability assay in Molt-4 cells","journal":"Current pharmaceutical biotechnology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — sequence-specific (mismatch controls used) splicing modulation with multiple functional readouts, single lab","pmids":["30727883"],"is_preprint":false}],"current_model":"DNTT (TdT) is a template-independent DNA polymerase that catalyzes the addition of random N-nucleotides to 3'-OH ends of DNA at V(D)J recombination junctions, generating junctional diversity in immunoglobulin and T-cell receptor genes; its activity is regulated by transcription factors (Ikaros competing with Ets activators, E47/E2A activating, c-Myc repressing), by post-translational kinase/phosphatase signaling (CK2 phosphorylation of Ikaros reduces TdT repression; PKA phosphorylation of TdT itself increases its endonuclease activity), and by direct protein inhibitors (TdIF1 blocks TdT access to DNA ends via the Pol beta-like domain, relieved by dsDNA; TReP-132 further reduces TdT activity); TdT expression is transiently induced on multipotent hematopoietic progenitors and progressively upregulated along the lymphoid trajectory, and is developmentally controlled in part by IL7Rα signaling."},"narrative":{"mechanistic_narrative":"DNTT (terminal deoxynucleotidyl transferase, TdT) is a template-independent DNA polymerase that generates antigen-receptor diversity by catalyzing random N-nucleotide addition to 3'-OH DNA ends at V(D)J recombination junctions; TdT-deficient mice completely lack N regions in immunoglobulin and T-cell receptor genes, while forced expression suppresses homology-directed joining and abolishes junctional homogeneity [PMID:8356451, PMID:8356452, PMID:7584135]. Its expression is tightly controlled along the lymphoid trajectory: it is transiently induced on multipotent progenitors and progressively upregulated toward lymphoid commitment [PMID:35354960], and depends on IL7Rα signaling in human B-cell precursors [PMID:27658954]. Transcriptionally, TdT is activated by E2A/E47 [PMID:8890174] and repressed by Ikaros dimers, which compete with an Ets activator at the promoter [PMID:11459831]—a repression relieved by CK2 phosphorylation of Ikaros and restored by PP1 [PMID:25214003]—and by a c-Myc/Max complex at the TdT initiator [PMID:7870572]. Enzyme activity is further restrained by direct protein inhibitors: TdIF1 binds the Pol-beta-like region to block access to DNA ends, an inhibition relieved when TdIF1 engages double-stranded DNA [PMID:17663723], and TReP-132 binds the TdT N-terminus to suppress activity [PMID:16371131]. Beyond physiological diversification, TdT primes replication slippage at NPM1 to generate AML-associated 4-bp insertions [PMID:31650162], and as a lymphoid-restricted antigen highly expressed in ALL it is both an immunotherapeutic target via HLA-A*02:01-presented peptides [PMID:34873326] and required for leukemia cell survival [PMID:30727883].","teleology":[{"year":1993,"claim":"Established the core physiological function of TdT: whether it is the enzyme actually responsible for junctional N-region diversity in antigen receptors, and whether its activity shapes the choice of joining pathway.","evidence":"TdT-deficient mice with direct V(D)J junction sequencing of Ig and TCR genes","pmids":["8356451","8356452"],"confidence":"High","gaps":["Does not define how TdT is recruited to the recombination machinery","Does not establish regulation of timing/level during development"]},{"year":1995,"claim":"Showed that TdT levels causally determine junctional repertoire structure, demonstrating gain-of-function suppression of canonical invariant junctions in fetal thymocytes.","evidence":"CD2-promoter TdT transgenic mice with TCR gamma-delta junction analysis","pmids":["7584135"],"confidence":"High","gaps":["Does not address endogenous control of fetal TdT silencing"]},{"year":1995,"claim":"Addressed how TdT transcription is negatively controlled at its initiation site, identifying c-Myc/Max repression of the TdT initiator.","evidence":"EMSA with supershift and co-transfection reporter assays","pmids":["7870572"],"confidence":"Medium","gaps":["No in vivo confirmation in developing lymphocytes","Mechanism of initiator repression not resolved"]},{"year":1996,"claim":"Identified a positive transcriptional regulator, showing TdT is a direct E2A target during early B-lineage commitment.","evidence":"E47 overexpression in fibroblasts with endogenous TdT transcription readout","pmids":["8890174"],"confidence":"Medium","gaps":["Single overexpression method","Direct promoter occupancy not shown"]},{"year":1996,"claim":"Probed post-translational control of the enzyme itself, showing PKA phosphorylation can switch TdT toward endonuclease activity.","evidence":"In vitro phosphorylation of recombinant TdT and endonuclease assay on supercoiled plasmid","pmids":["8667637"],"confidence":"Medium","gaps":["Single in vitro method, not validated in cells","Physiological relevance of endonuclease conversion unclear"]},{"year":2001,"claim":"Defined the mechanism of TdT down-regulation during thymocyte differentiation, showing Ikaros competes with an Ets activator at the promoter and couples repression to chromatin change.","evidence":"Competition binding, promoter mutagenesis in integrated reporter, chromatin accessibility, thymocyte differentiation","pmids":["11459831"],"confidence":"High","gaps":["Identity of the Ets activator not fully resolved","Link between accessibility change and pericentromeric repositioning correlative"]},{"year":2006,"claim":"Identified a direct protein inhibitor acting through the TdT N-terminus, expanding the set of negative regulators during V(D)J recombination.","evidence":"Yeast two-hybrid, pull-down, co-IP, in vitro activity assay, co-localization in COS7 cells","pmids":["16371131"],"confidence":"Medium","gaps":["In vivo relevance during recombination not established","Structural basis of inhibition unknown"]},{"year":2007,"claim":"Resolved how TdIF1 inhibits TdT and how the inhibition is relieved, mapping a DNA-sensing switch that targets TdT to AT-rich DNA.","evidence":"Domain analysis, binding assays, in vitro TdT activity assays with dsDNA primer","pmids":["17663723"],"confidence":"Medium","gaps":["No structure of the TdT-TdIF1 complex","In vivo consequence of the dsDNA-triggered release not shown"]},{"year":2014,"claim":"Connected kinase/phosphatase signaling to TdT transcription, showing CK2 phosphorylation of Ikaros relieves and PP1 restores TdT repression.","evidence":"Ikaros phosphomutants, CK2/PP1 inhibitors, qChIP and qRT-PCR in thymocytes and leukemia cells","pmids":["25214003"],"confidence":"Medium","gaps":["Single lab","Does not establish CK2-Ikaros axis as the dominant control in normal development"]},{"year":2016,"claim":"Established a developmental signaling input controlling TdT levels in humans, linking IL7Rα signaling to TdT expression and N-region length.","evidence":"Ig rearrangement sequencing and expression in fetal precursors and IL7Rα-deficient patient samples","pmids":["27658954"],"confidence":"Medium","gaps":["Downstream effectors linking IL7Rα to TdT transcription unknown","Single study"]},{"year":2019,"claim":"Extended TdT's mutagenic activity to leukemogenesis, modeling how N-addition primes replication slippage to generate recurrent NPM1 4-bp insertions in AML.","evidence":"Large-scale analysis of 2430 NPM1 mutations with predictive statistical modeling and pediatric/adult comparison","pmids":["31650162"],"confidence":"Medium","gaps":["No direct in vitro reconstitution of the slippage mechanism","Correlative inference of TdT activity from sequence features"]},{"year":2019,"claim":"Tested whether TdT is required for survival of TdT-expressing leukemia, establishing a dependency through splicing-based knockdown.","evidence":"PNA splicing modulation with apoptosis and viability readouts in Molt-4 cells","pmids":["30727883"],"confidence":"Medium","gaps":["Single cell line","Mechanism linking TdT loss to apoptosis not defined"]},{"year":2021,"claim":"Exploited TdT as a lymphoid-restricted antigen, demonstrating engineered TCRs against TdT peptides eliminate ALL while sparing normal cells.","evidence":"TCR engineering, in vitro cytotoxicity, three B-ALL mouse models, humanized mice for normal cell sparing","pmids":["34873326"],"confidence":"High","gaps":["Restricted to HLA-A*02:01 context","Long-term durability and escape not addressed"]},{"year":2022,"claim":"Mapped where TdT is first induced in hematopoiesis, identifying a multipotent progenitor subset with transient TdT and defining the lymphoid trajectory.","evidence":"TdT reporter and lineage-tracing mice with single-cell CITE-seq and differentiation assays","pmids":["35354960"],"confidence":"High","gaps":["Transcriptional trigger for transient TdT induction in MPPs unknown","Functional role of TdT in MPPs beyond marking lineage not established"]},{"year":null,"claim":"How the multiple transcriptional, signaling, and protein-inhibitor inputs are integrated to set TdT activity precisely at the recombinase, and the structural basis of its regulation, remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of TdT bound to its protein inhibitors","Hierarchy among E2A activation, Ikaros/c-Myc repression, and IL7Rα control during normal development undefined","Direct mechanistic link between TdT and replication slippage at NPM1 not reconstituted"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,1,2,3,12]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,3]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,8]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,1,2,16]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,17,19]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,5,6,9]}],"complexes":[],"partners":["TDIF1","TREP-132","IKAROS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P04053","full_name":"DNA nucleotidylexotransferase","aliases":["Terminal addition enzyme","Terminal deoxynucleotidyltransferase","Terminal transferase"],"length_aa":509,"mass_kda":58.5,"function":"Template-independent DNA polymerase which catalyzes the random addition of deoxynucleoside 5'-triphosphate to the 3'-end of a DNA initiator. One of the in vivo functions of this enzyme is the addition of nucleotides at the junction (N region) of rearranged Ig heavy chain and T-cell receptor gene segments during the maturation of B- and T-cells","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P04053/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DNTT","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DNTT","total_profiled":1310},"omim":[{"mim_id":"617200","title":"OLIGODENDROCYTIC MYELIN PARANODAL AND INNER LOOP PROTEIN; OPALIN","url":"https://www.omim.org/entry/617200"},{"mim_id":"611388","title":"DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL, INTERACTING PROTEIN 1; DNTTIP1","url":"https://www.omim.org/entry/611388"},{"mim_id":"611199","title":"DNTT-INTERACTING PROTEIN 2; DNTTIP2","url":"https://www.omim.org/entry/611199"},{"mim_id":"601752","title":"ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENTPD1","url":"https://www.omim.org/entry/601752"},{"mim_id":"187410","title":"DEOXYNUCLEOTIDYLTRANSFERASE, TERMINAL; DNTT","url":"https://www.omim.org/entry/187410"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"lymphoid tissue","ntpm":306.4}],"url":"https://www.proteinatlas.org/search/DNTT"},"hgnc":{"alias_symbol":["TDT","TdT"],"prev_symbol":[]},"alphafold":{"accession":"P04053","domains":[{"cath_id":"3.40.50.10190","chopping":"33-114","consensus_level":"high","plddt":87.7476,"start":33,"end":114},{"cath_id":"1.10.150.110","chopping":"155-242","consensus_level":"high","plddt":96.6687,"start":155,"end":242},{"cath_id":"1.10.150.20","chopping":"244-301","consensus_level":"medium","plddt":97.1748,"start":244,"end":301},{"cath_id":"3.30.460.10","chopping":"304-507","consensus_level":"medium","plddt":93.5965,"start":304,"end":507}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P04053","model_url":"https://alphafold.ebi.ac.uk/files/AF-P04053-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P04053-F1-predicted_aligned_error_v6.png","plddt_mean":88.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DNTT","jax_strain_url":"https://www.jax.org/strain/search?query=DNTT"},"sequence":{"accession":"P04053","fasta_url":"https://rest.uniprot.org/uniprotkb/P04053.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P04053/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P04053"}},"corpus_meta":[{"pmid":"8356451","id":"PMC_8356451","title":"Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8356451","citation_count":385,"is_preprint":false},{"pmid":"8356452","id":"PMC_8356452","title":"Mice lacking TdT: mature animals with an immature lymphocyte repertoire.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8356452","citation_count":368,"is_preprint":false},{"pmid":"10747040","id":"PMC_10747040","title":"DNA polymerase mu (Pol mu), homologous to TdT, could act as a DNA mutator in eukaryotic cells.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10747040","citation_count":234,"is_preprint":false},{"pmid":"11459831","id":"PMC_11459831","title":"Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11459831","citation_count":123,"is_preprint":false},{"pmid":"1249420","id":"PMC_1249420","title":"The distribution of terminal deoxynucleotidyl transferase (TdT) among subsets of thymocytes in the rat.","date":"1976","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/1249420","citation_count":122,"is_preprint":false},{"pmid":"281253","id":"PMC_281253","title":"Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia.","date":"1978","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/281253","citation_count":115,"is_preprint":false},{"pmid":"2413114","id":"PMC_2413114","title":"Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.","date":"1985","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2413114","citation_count":98,"is_preprint":false},{"pmid":"12015765","id":"PMC_12015765","title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.","date":"2002","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12015765","citation_count":93,"is_preprint":false},{"pmid":"8890174","id":"PMC_8890174","title":"E47 activates the Ig-heavy chain and TdT loci in non-B cells.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8890174","citation_count":87,"is_preprint":false},{"pmid":"17885674","id":"PMC_17885674","title":"TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis.","date":"2007","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/17885674","citation_count":85,"is_preprint":false},{"pmid":"1279324","id":"PMC_1279324","title":"The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.","date":"1992","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/1279324","citation_count":68,"is_preprint":false},{"pmid":"9271626","id":"PMC_9271626","title":"Characterization of rainbow trout terminal deoxynucleotidyl transferase structure and expression. TdT and RAG1 co-expression define the trout primary lymphoid tissues.","date":"1997","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9271626","citation_count":65,"is_preprint":false},{"pmid":"10738544","id":"PMC_10738544","title":"A logistic regression based extension of the TDT for continuous and categorical traits.","date":"1999","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10738544","citation_count":62,"is_preprint":false},{"pmid":"6733275","id":"PMC_6733275","title":"TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings.","date":"1984","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/6733275","citation_count":61,"is_preprint":false},{"pmid":"10441334","id":"PMC_10441334","title":"Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10441334","citation_count":60,"is_preprint":false},{"pmid":"1684099","id":"PMC_1684099","title":"A molecular genetic linkage map of mouse chromosome 19, including the lpr, Ly-44, and Tdt genes.","date":"1991","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1684099","citation_count":60,"is_preprint":false},{"pmid":"23060347","id":"PMC_23060347","title":"TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.","date":"2012","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23060347","citation_count":56,"is_preprint":false},{"pmid":"16133186","id":"PMC_16133186","title":"TDT-association analysis of EKN1 and dyslexia in a Colorado twin cohort.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16133186","citation_count":54,"is_preprint":false},{"pmid":"30181564","id":"PMC_30181564","title":"High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.","date":"2018","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/30181564","citation_count":52,"is_preprint":false},{"pmid":"7584135","id":"PMC_7584135","title":"The role of short homology repeats and TdT in generation of the invariant gamma delta antigen receptor repertoire in the fetal thymus.","date":"1995","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/7584135","citation_count":51,"is_preprint":false},{"pmid":"7587710","id":"PMC_7587710","title":"Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells.","date":"1995","source":"Cytometry","url":"https://pubmed.ncbi.nlm.nih.gov/7587710","citation_count":51,"is_preprint":false},{"pmid":"27592241","id":"PMC_27592241","title":"Target-triggered catalytic hairpin assembly and TdT-catalyzed DNA polymerization for amplified electronic detection of thrombin in human serums.","date":"2016","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/27592241","citation_count":50,"is_preprint":false},{"pmid":"11595019","id":"PMC_11595019","title":"Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences.","date":"2001","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11595019","citation_count":49,"is_preprint":false},{"pmid":"9343323","id":"PMC_9343323","title":"MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.","date":"1997","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9343323","citation_count":48,"is_preprint":false},{"pmid":"7688837","id":"PMC_7688837","title":"Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.","date":"1993","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/7688837","citation_count":47,"is_preprint":false},{"pmid":"18480005","id":"PMC_18480005","title":"Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.","date":"2008","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18480005","citation_count":47,"is_preprint":false},{"pmid":"8667637","id":"PMC_8667637","title":"Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells.","date":"1996","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/8667637","citation_count":45,"is_preprint":false},{"pmid":"6343731","id":"PMC_6343731","title":"Distinct lymphoblastic and myeloblastic populations in TdT positive acute myeloblastic leukemia: evidence by double-fluorescence staining.","date":"1983","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/6343731","citation_count":45,"is_preprint":false},{"pmid":"9433566","id":"PMC_9433566","title":"Linkage disequilibrium between the dopamine transporter gene (DAT1) and bipolar disorder: extending the transmission disequilibrium test (TDT) to examine genetic heterogeneity.","date":"1997","source":"Genetic epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/9433566","citation_count":43,"is_preprint":false},{"pmid":"21571955","id":"PMC_21571955","title":"Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma.","date":"2011","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21571955","citation_count":42,"is_preprint":false},{"pmid":"7870572","id":"PMC_7870572","title":"The c-myc protein represses the lambda 5 and TdT initiators.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7870572","citation_count":41,"is_preprint":false},{"pmid":"23536781","id":"PMC_23536781","title":"MTHFR C677T polymorphism and risk of congenital heart defects: evidence from 29 case-control and TDT studies.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23536781","citation_count":41,"is_preprint":false},{"pmid":"23329999","id":"PMC_23329999","title":"Immunohistochemical expression of PAX5 and TdT by Merkel cell carcinoma and pulmonary small cell carcinoma: a potential diagnostic pitfall but useful discriminatory marker.","date":"2013","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23329999","citation_count":41,"is_preprint":false},{"pmid":"1998595","id":"PMC_1998595","title":"Combined flow cytometric assessment of cell surface antigens and nuclear TdT for the detection of minimal residual disease in acute leukaemia.","date":"1991","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/1998595","citation_count":39,"is_preprint":false},{"pmid":"6210337","id":"PMC_6210337","title":"A selective culture system for generating terminal deoxynucleotidyl transferase-positive (TdT+) lymphoid precursor cells in vitro. I. Description of the culture system.","date":"1984","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/6210337","citation_count":38,"is_preprint":false},{"pmid":"26892631","id":"PMC_26892631","title":"Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.","date":"2016","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/26892631","citation_count":37,"is_preprint":false},{"pmid":"17196657","id":"PMC_17196657","title":"Evidence for preferential Ig gene usage and differential TdT and exonuclease activities in human naïve and memory B cells.","date":"2006","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17196657","citation_count":37,"is_preprint":false},{"pmid":"25118111","id":"PMC_25118111","title":"A TdT-mediated cascade signal amplification strategy based on dendritic DNA matrix for label-free multifunctional electrochemical biosensing.","date":"2014","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/25118111","citation_count":36,"is_preprint":false},{"pmid":"3347092","id":"PMC_3347092","title":"Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL.","date":"1988","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/3347092","citation_count":34,"is_preprint":false},{"pmid":"34392269","id":"PMC_34392269","title":"Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity.","date":"2022","source":"The American journal of surgical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34392269","citation_count":33,"is_preprint":false},{"pmid":"31650162","id":"PMC_31650162","title":"Molecular roulette: nucleophosmin mutations in AML are orchestrated through N-nucleotide addition by TdT.","date":"2019","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/31650162","citation_count":33,"is_preprint":false},{"pmid":"9110287","id":"PMC_9110287","title":"013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.","date":"1997","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/9110287","citation_count":33,"is_preprint":false},{"pmid":"35354960","id":"PMC_35354960","title":"Dntt expression reveals developmental hierarchy and lineage specification of hematopoietic progenitors.","date":"2022","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35354960","citation_count":29,"is_preprint":false},{"pmid":"34873326","id":"PMC_34873326","title":"T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.","date":"2021","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/34873326","citation_count":29,"is_preprint":false},{"pmid":"6935216","id":"PMC_6935216","title":"A micromethod for determination of terminal deoxynucleotidyl transferase (TdT) in the diagnostic evaluation of acute leukemias.","date":"1980","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/6935216","citation_count":29,"is_preprint":false},{"pmid":"3288272","id":"PMC_3288272","title":"TdT positive B-cell acute lymphoblastic leukaemia (B-ALL) without Burkitt characteristics.","date":"1988","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/3288272","citation_count":28,"is_preprint":false},{"pmid":"17625508","id":"PMC_17625508","title":"VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies.","date":"2007","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/17625508","citation_count":27,"is_preprint":false},{"pmid":"3088880","id":"PMC_3088880","title":"Incidence of TdT positivity in cases of leukemia and lymphoma.","date":"1986","source":"Acta haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/3088880","citation_count":26,"is_preprint":false},{"pmid":"36574685","id":"PMC_36574685","title":"Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/36574685","citation_count":25,"is_preprint":false},{"pmid":"11013135","id":"PMC_11013135","title":"General equations for Pt, Ps, and the power of the TDT and the affected-sib-pair test.","date":"2000","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11013135","citation_count":25,"is_preprint":false},{"pmid":"8609368","id":"PMC_8609368","title":"Enhancement of TdT-mediated dUTP-biotin nick end-labeling (TUNEL) method using mung bean nuclease, a single-stranded DNA digestion enzyme.","date":"1996","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/8609368","citation_count":25,"is_preprint":false},{"pmid":"8884428","id":"PMC_8884428","title":"Repertoires of antigen receptors in Tdt congenitally deficient mice.","date":"1996","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8884428","citation_count":24,"is_preprint":false},{"pmid":"10036787","id":"PMC_10036787","title":"In vivo incidence of apoptosis evaluated with the TdT FragEL DNA fragmentation detection kit in cartilage and bone cells of the rat tibia.","date":"1998","source":"Tissue & cell","url":"https://pubmed.ncbi.nlm.nih.gov/10036787","citation_count":24,"is_preprint":false},{"pmid":"16818769","id":"PMC_16818769","title":"Paucity of V-D-D-J rearrangements and VH replacement events in lupus prone and nonautoimmune TdT-/- and TdT+/+ mice.","date":"2006","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/16818769","citation_count":23,"is_preprint":false},{"pmid":"3296354","id":"PMC_3296354","title":"Regeneration of TdT+, pre-B, and B cells in bone marrow after allogeneic bone marrow transplantation.","date":"1987","source":"Transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/3296354","citation_count":23,"is_preprint":false},{"pmid":"30727883","id":"PMC_30727883","title":"Downregulation of TdT Expression through Splicing Modulation by Antisense Peptide Nucleic Acid (PNA).","date":"2019","source":"Current pharmaceutical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/30727883","citation_count":22,"is_preprint":false},{"pmid":"7587711","id":"PMC_7587711","title":"Adaptation of the TdT assay for semi-quantitative flow cytometric detection of DNA strand breaks.","date":"1995","source":"Cytometry","url":"https://pubmed.ncbi.nlm.nih.gov/7587711","citation_count":22,"is_preprint":false},{"pmid":"27658954","id":"PMC_27658954","title":"Decreased IL7Rα and TdT expression underlie the skewed immunoglobulin repertoire of human B-cell precursors from fetal origin.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27658954","citation_count":21,"is_preprint":false},{"pmid":"25214003","id":"PMC_25214003","title":"Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.","date":"2014","source":"Pediatric blood & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25214003","citation_count":21,"is_preprint":false},{"pmid":"22400079","id":"PMC_22400079","title":"TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.","date":"2012","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22400079","citation_count":21,"is_preprint":false},{"pmid":"12707933","id":"PMC_12707933","title":"N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case-control analyses.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12707933","citation_count":21,"is_preprint":false},{"pmid":"2836001","id":"PMC_2836001","title":"2',3'-Dideoxyadenosine is selectively toxic for TdT-positive cells.","date":"1988","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/2836001","citation_count":21,"is_preprint":false},{"pmid":"28875336","id":"PMC_28875336","title":"Progression of liver fibrosis can be controlled by adequate chelation in transfusion-dependent thalassemia (TDT).","date":"2017","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/28875336","citation_count":21,"is_preprint":false},{"pmid":"31987151","id":"PMC_31987151","title":"A \"signal-on\" electrochemical biosensor based on DNAzyme-driven bipedal DNA walkers and TdT-mediated cascade signal amplification strategy.","date":"2019","source":"Analytica chimica acta","url":"https://pubmed.ncbi.nlm.nih.gov/31987151","citation_count":20,"is_preprint":false},{"pmid":"3493393","id":"PMC_3493393","title":"Multiple chromosome abnormalities in a drug resistant TdT positive B-cell leukemia.","date":"1987","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/3493393","citation_count":20,"is_preprint":false},{"pmid":"32045813","id":"PMC_32045813","title":"ExoIII and TdT dependent isothermal amplification (ETDA) colorimetric biosensor for ultra-sensitive detection of Hg2.","date":"2020","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32045813","citation_count":19,"is_preprint":false},{"pmid":"28544921","id":"PMC_28544921","title":"In situ formed copper nanoparticles templated by TdT-mediated DNA for enhanced SPR sensor-based DNA assay.","date":"2017","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/28544921","citation_count":19,"is_preprint":false},{"pmid":"8217792","id":"PMC_8217792","title":"Differential expression of terminal transferase (TdT) in acute lymphocytic leukaemia expressing myeloid antigens and TdT positive acute myeloid leukaemia as compared to myeloid antigen negative acute lymphocytic leukaemia.","date":"1993","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/8217792","citation_count":19,"is_preprint":false},{"pmid":"12174218","id":"PMC_12174218","title":"Robust TDT-type candidate-gene association tests.","date":"2002","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12174218","citation_count":18,"is_preprint":false},{"pmid":"36700990","id":"PMC_36700990","title":"Fluorescent aptasensor based on the MNPs-CRISPR/Cas12a-TdT for the determination of nasopharyngeal carcinoma-derived exosomes.","date":"2023","source":"Mikrochimica acta","url":"https://pubmed.ncbi.nlm.nih.gov/36700990","citation_count":18,"is_preprint":false},{"pmid":"11888163","id":"PMC_11888163","title":"Characterization of tdt genes for the degradation of tricyclic diterpenes by Pseudomonas diterpeniphila A19-6a.","date":"2002","source":"Canadian journal of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11888163","citation_count":18,"is_preprint":false},{"pmid":"2439117","id":"PMC_2439117","title":"Biochemistry of terminal deoxynucleotidyltransferase (TdT): characterization and mechanism of inhibition of TdT by P1, P5-bis(5'-adenosyl) pentaphosphate.","date":"1987","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2439117","citation_count":18,"is_preprint":false},{"pmid":"1689438","id":"PMC_1689438","title":"Lack of correlation between immunoglobulin and T cell receptor gene rearrangements and TdT expression in acute myeloid leukaemia.","date":"1990","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/1689438","citation_count":18,"is_preprint":false},{"pmid":"31126452","id":"PMC_31126452","title":"Highly sensitive aflatoxin B1 sensor based on DNA-guided assembly of fluorescent probe and TdT-assisted DNA polymerization.","date":"2019","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31126452","citation_count":18,"is_preprint":false},{"pmid":"7596835","id":"PMC_7596835","title":"T-cell specific avian TdT: characterization of the cDNA and recombinant enzyme.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7596835","citation_count":17,"is_preprint":false},{"pmid":"33528622","id":"PMC_33528622","title":"Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.","date":"2021","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33528622","citation_count":17,"is_preprint":false},{"pmid":"32134459","id":"PMC_32134459","title":"TdT Expression Is a Marker of Better Survival in Merkel Cell Carcinoma, and Expression of B-Cell Markers Is Associated With Merkel Cell Polyomavirus.","date":"2020","source":"American journal of clinical pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32134459","citation_count":17,"is_preprint":false},{"pmid":"22481022","id":"PMC_22481022","title":"Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.","date":"2012","source":"Clinical lymphoma, myeloma & leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/22481022","citation_count":17,"is_preprint":false},{"pmid":"16417922","id":"PMC_16417922","title":"Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.","date":"2006","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/16417922","citation_count":16,"is_preprint":false},{"pmid":"17663723","id":"PMC_17663723","title":"Identification of functional domains in TdIF1 and its inhibitory mechanism for TdT activity.","date":"2007","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/17663723","citation_count":16,"is_preprint":false},{"pmid":"2647840","id":"PMC_2647840","title":"Detection of terminal deoxynucleotidyl transferase (TdT) by flow cytometry in leukemic disorders.","date":"1989","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/2647840","citation_count":16,"is_preprint":false},{"pmid":"15146297","id":"PMC_15146297","title":"Early expression of two TdT isoforms in the hematopoietic system of the Mexican axolotl. Implications for the evolutionary origin of the N-nucleotide addition.","date":"2004","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/15146297","citation_count":16,"is_preprint":false},{"pmid":"25862087","id":"PMC_25862087","title":"On the use of an appropriate TdT-mediated dUTP-biotin nick end labeling assay to identify apoptotic cells.","date":"2015","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25862087","citation_count":16,"is_preprint":false},{"pmid":"9845437","id":"PMC_9845437","title":"Propidium iodide quenches the fluorescence of TdT-incorporated FITC-labeled dUTP in apoptotic cells.","date":"1998","source":"Cytometry","url":"https://pubmed.ncbi.nlm.nih.gov/9845437","citation_count":15,"is_preprint":false},{"pmid":"31203177","id":"PMC_31203177","title":"Terminal deoxynucleotidyl transferase (TdT)-catalyzed homo-nucleotides-constituted ssDNA: Inducing tunable-size nanogap for core-shell plasmonic metal nanostructure and acting as Raman reporters for detection of Escherichia coli O157:H7.","date":"2019","source":"Biosensors & bioelectronics","url":"https://pubmed.ncbi.nlm.nih.gov/31203177","citation_count":15,"is_preprint":false},{"pmid":"7723388","id":"PMC_7723388","title":"Differential TdT expression in acute leukemia by flow cytometry: a quantitative study.","date":"1995","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/7723388","citation_count":14,"is_preprint":false},{"pmid":"3155660","id":"PMC_3155660","title":"Antigenic phenotype of TdT-positive cells in human peripheral blood.","date":"1985","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/3155660","citation_count":14,"is_preprint":false},{"pmid":"36880583","id":"PMC_36880583","title":"A Quenched Size-Expanded Nucleotide Reports Activity of the Leukemia Biomarker Terminal Deoxynucleotidyl Transferase (TdT).","date":"2023","source":"Angewandte Chemie (International ed. in English)","url":"https://pubmed.ncbi.nlm.nih.gov/36880583","citation_count":13,"is_preprint":false},{"pmid":"29615769","id":"PMC_29615769","title":"Simultaneous Monitoring of Cell-surface Receptor and Tumor-targeted Photodynamic Therapy via TdT-initiated Poly-G-Quadruplexes.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29615769","citation_count":13,"is_preprint":false},{"pmid":"35565429","id":"PMC_35565429","title":"CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35565429","citation_count":12,"is_preprint":false},{"pmid":"29187045","id":"PMC_29187045","title":"Terminal Deoxynucleotidyl Transferase (TdT)-negative Lymphoblastic Leukemia in Pediatric Patients: Incidence and Clinical Significance.","date":"2017","source":"Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society","url":"https://pubmed.ncbi.nlm.nih.gov/29187045","citation_count":12,"is_preprint":false},{"pmid":"3036570","id":"PMC_3036570","title":"Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin.","date":"1987","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/3036570","citation_count":12,"is_preprint":false},{"pmid":"16371131","id":"PMC_16371131","title":"Direct binding of TReP-132 with TdT results in reduction of TdT activity.","date":"2006","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/16371131","citation_count":12,"is_preprint":false},{"pmid":"28884033","id":"PMC_28884033","title":"High-Grade B-Cell Neoplasm with Surface Light Chain Restriction and Tdt Coexpression Evolved in a MYC-Rearranged Diffuse Large B-Cell Lymphoma: A Dilemma in Classification.","date":"2017","source":"Case reports in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/28884033","citation_count":12,"is_preprint":false},{"pmid":"9353824","id":"PMC_9353824","title":"Detection of terminal deoxynucleotidyl transferase (TdT) in nonhematopoietic small round cell tumors of children.","date":"1997","source":"Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association","url":"https://pubmed.ncbi.nlm.nih.gov/9353824","citation_count":12,"is_preprint":false},{"pmid":"32887095","id":"PMC_32887095","title":"DSN/TdT recycling digestion based cyclic amplification strategy for microRNA assay.","date":"2020","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/32887095","citation_count":11,"is_preprint":false},{"pmid":"3461712","id":"PMC_3461712","title":"TdT activity in acute myeloid leukemias defined by monoclonal antibodies.","date":"1986","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/3461712","citation_count":11,"is_preprint":false},{"pmid":"27456743","id":"PMC_27456743","title":"TdT-Positive, SmIg-Negative B Precursor Cell Leukemia with Burkitt Morphology: A Case Report.","date":"1990","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/27456743","citation_count":11,"is_preprint":false},{"pmid":"22678881","id":"PMC_22678881","title":"Incorporating genotype uncertainties into the genotypic TDT for main effects and gene-environment interactions.","date":"2012","source":"Genetic epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/22678881","citation_count":11,"is_preprint":false},{"pmid":"2733453","id":"PMC_2733453","title":"TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.","date":"1989","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/2733453","citation_count":10,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49466,"output_tokens":4998,"usd":0.111684,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13253,"output_tokens":3924,"usd":0.082183,"stage2_stop_reason":"end_turn"},"total_usd":0.193867,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"TdT is responsible for template-independent N-region nucleotide addition at V(D)J gene segment junctions. TdT-deficient mice completely lack N regions in immunoglobulin and T cell receptor variable region genes, proving TdT is the enzyme responsible for junctional diversity.\",\n      \"method\": \"Genetic knockout (TdT-deficient mice), sequence analysis of V(D)J junctions\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent labs published simultaneously using TdT knockout mice with direct sequencing of receptor genes, replicated across studies\",\n      \"pmids\": [\"8356451\", \"8356452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"TdT expression in adult mice blocks homology-directed (P-nucleotide/microhomology) V(D)J recombination; TdT-deficient adult mice show extensive homology-directed recombination, indicating TdT's N-addition activity suppresses this alternative joining pathway.\",\n      \"method\": \"Genetic knockout (TdT-deficient mice), sequence analysis of V(D)J junctions\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — demonstrated in TdT knockout mouse model with direct sequence evidence, replicated independently\",\n      \"pmids\": [\"8356452\", \"8356451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Forced TdT expression (via CD2-promoter transgene) in fetal thymus V gamma 3+ T cells markedly reduces the frequency of canonical invariant TCR gamma-delta junctions and increases non-canonical junctions with N nucleotides, demonstrating TdT activity directly inhibits junctional homogeneity in fetal thymocytes.\",\n      \"method\": \"Transgenic mouse overexpression of TdT, analysis of TCR gamma-delta junctions\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgenic gain-of-function with direct sequence readout, single lab with clear phenotypic result\",\n      \"pmids\": [\"7584135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"TdT catalysis is strongly inhibited by Ap5A (P1,P5-bis(5'-adenosyl) pentaphosphate) through interaction at both the dNTP substrate binding domain and the DNA primer binding domain; kinetic analysis showed competitive inhibition at both sites with a Ki ~0.25 µM when both domains are available.\",\n      \"method\": \"In vitro enzyme kinetics, UV cross-linking of substrate/primer to TdT, borohydride reduction trapping with oxidized Ap5A\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted in vitro biochemical assay with multiple orthogonal methods (kinetics, crosslinking, covalent trapping), single lab\",\n      \"pmids\": [\"2439117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Ikaros protein dimers compete with an Ets transcription factor activator for occupancy of the TdT promoter to repress TdT transcription during CD4+CD8+ thymocyte differentiation. Mutations that selectively disrupt Ikaros binding to the integrated TdT promoter abolish down-regulation upon differentiation. Chromatin alterations accompany Ikaros-mediated TdT repression, preceding pericentromeric repositioning.\",\n      \"method\": \"Binding/competition assays, promoter mutagenesis in integrated TdT reporter, chromatin accessibility (restriction enzyme assay), differentiation of CD4+CD8+ thymocyte line\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (competition binding, mutagenesis, chromatin accessibility, differentiation assay), single lab\",\n      \"pmids\": [\"11459831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"E47 (E2A protein) activates the endogenous chromosomal TdT gene when overexpressed in non-B (fibroblast) cells, demonstrating TdT is a direct transcriptional target of E2A proteins early in B-cell lineage commitment.\",\n      \"method\": \"Stable transfection/overexpression of E47, measurement of endogenous TdT transcription\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — stable cell line overexpression with endogenous gene readout, single lab, single method\",\n      \"pmids\": [\"8890174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"c-Myc/Myn (Max) protein complex binds to the TdT initiator element (InrTdT) at the transcription initiation site, and c-Myc overexpression represses transcriptional activity of the TdT initiator in co-transfection assays.\",\n      \"method\": \"Gel retardation (EMSA), co-transfection/reporter assay, supershift with specific antibodies\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — EMSA with antibody confirmation plus functional reporter assay, single lab\",\n      \"pmids\": [\"7870572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"TReP-132 directly binds TdT through TdT's N-terminal region and reduces TdT activity to 2.5% of maximum in vitro. TReP-132 also binds TdIF1, and all three proteins co-localize in the nucleus, suggesting TReP-132 negatively regulates TdT during V(D)J recombination.\",\n      \"method\": \"Yeast two-hybrid, pull-down assay, immunoprecipitation, in vitro TdT activity assay, co-localization by immunofluorescence in COS7 cells\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid confirmed by pull-down and co-IP plus in vitro activity assay, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"16371131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TdIF1 (TdT-interacting factor 1) binds to the Pol beta-like region in TdT and blocks TdT access to DNA ends, thereby inhibiting TdT activity. In the presence of double-stranded DNA, TdIF1 binds dsDNA through AT-hook-like motif and helix-turn-helix motif, releasing TdT to concentrate near AT-rich DNA for synthesis. Functional domains in TdIF1 include TdT-binding, DNA-binding (three regions), dimerization, and a bipartite NLS overlapping the AT-hook-like motif.\",\n      \"method\": \"Bioinformatics domain analysis, binding assays (pull-down, co-IP), in vitro TdT activity assays with dsDNA primer\",\n      \"journal\": \"Genes to cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro activity assay plus binding assays, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"17663723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CK2 (Casein Kinase II) phosphorylation of Ikaros decreases Ikaros binding to the TdT promoter and reduces Ikaros-mediated transcriptional repression of TdT in thymocytes and T-cell leukemia. PP1 (Protein Phosphatase 1) activity restores Ikaros DNA-binding affinity at the TdT promoter and Ikaros-mediated TdT repression. CK2 inhibition also restores TdT repression.\",\n      \"method\": \"Ikaros phosphomimetic/phosphoresistant mutants, CK2 and PP1 inhibitors, quantitative ChIP (qChIP), qRT-PCR in primary thymocytes and leukemia cells\",\n      \"journal\": \"Pediatric blood & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mutants plus pharmacological inhibitors with orthogonal chromatin and transcript readouts, single lab\",\n      \"pmids\": [\"25214003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TdT primes replication slippage at NPM1 to generate AML-associated 4-bp insertion mutations through N-nucleotide addition. Analysis of 2430 NPM1 mutations showed G/C-rich N-nucleotide tracts with polypurine/polypyrimidine stacking bias consistent with TdT synthesis; the TdT-mutator model predicted the relative incidence of 256 potential 4-bp insertions with significant correlation (ρ=0.484). Higher TdT activity in pediatric myeloid cells correlates with longer N-regions in pediatric vs. adult NPM1 mutations.\",\n      \"method\": \"Large-scale mutational analysis (2430 mutations), statistical modeling, comparison of pediatric vs. adult mutation spectra\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — large-scale sequence analysis with predictive modeling, single study but very large dataset with statistical validation; no direct in vitro reconstitution\",\n      \"pmids\": [\"31650162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"TdT mediates selective cytotoxicity of 2',3'-dideoxyadenosine (ddA) in TdT-positive cells by chain-terminating addition of ddAMP to DNA. A pre-B cell line rendered TdT-positive by retroviral TdT cDNA transduction showed 90% cell death vs. 30% in the TdT-negative parental line under ddA/coformycin treatment, directly demonstrating TdT's role in ddA cytotoxicity.\",\n      \"method\": \"Retroviral TdT cDNA transduction of TdT-negative cell line, cell viability assay with ddA/CF treatment\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isogenic cell line pair (TdT+/− by retroviral transduction) with direct cytotoxicity comparison, single lab\",\n      \"pmids\": [\"2836001\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Phosphorylation of recombinant TdT by protein kinase A (PKA) dramatically increases its endonuclease activity on supercoiled plasmid DNA in cell-free experiments, converting it to a linearizing endonuclease.\",\n      \"method\": \"In vitro phosphorylation of recombinant TdT by PKA, endonuclease assay on supercoiled plasmid DNA\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reconstitution with recombinant enzyme plus kinase, single lab, single method, preliminary finding\",\n      \"pmids\": [\"8667637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TdT has been highly conserved (>70% amino acid similarity) across vertebrate evolution (trout, chicken, Xenopus, mouse, human, cattle). Structural alignment with rat DNA polymerase beta supports the hypothesis that TdT and Pol beta evolved from a common ancestral repair polymerase. Four PKC phosphorylation sites are conserved across species, suggesting a role for PKC in TdT regulation.\",\n      \"method\": \"cDNA cloning and sequencing, Northern blot, RT-PCR, phylogenetic/structural alignment with rat Pol beta crystal structure\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — evolutionary sequence comparison and expression analysis; PKC site conservation is computational inference without functional validation\",\n      \"pmids\": [\"9271626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In the Mexican axolotl, two TdT isoforms exist: TdT1 (full-length, with all conserved catalytic motifs) and TdT2 (lacking the first helix-hairpin-helix DNA-binding motif due to 57-amino acid internal deletion). TdT and Pol mu are closely related paralogs that were already present in the common ancestor of jawed vertebrates.\",\n      \"method\": \"cDNA cloning, sequence analysis, phylogenetic analysis, RT-PCR developmental expression\",\n      \"journal\": \"Immunogenetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — sequence/phylogenetic analysis without direct functional validation of each isoform's activity\",\n      \"pmids\": [\"15146297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In human fetal B-cell precursors, TdT expression is lower than in pediatric bone marrow precursors, correlating with fewer N-nucleotide additions in IGH gene rearrangements. IL7Rα signaling is required for TdT expression: B-cell progenitors from IL7Rα-deficient patients had reduced TdT expression and fewer N-nucleotide additions at Dh-Jh junctions.\",\n      \"method\": \"Molecular analysis of Ig gene rearrangements, quantitative expression analysis, analysis of IL7Rα-deficient patient samples\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human patient genetic deficiency combined with molecular sequencing analysis, multiple cohorts, single study\",\n      \"pmids\": [\"27658954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Using TdT reporter and lineage-tracing transgenic mice, transient TdT induction was detected on a newly identified multipotent progenitor (MPP) subset within MPP4 lacking self-renewal but retaining multilineage differentiation potential. Stable and progressive TdT upregulation defined the lymphoid developmental trajectory. TdT+ MPP multipotency was associated with ESAM expression, and ESAM downregulation marked progressive loss of alternative fates along all lineages.\",\n      \"method\": \"Transgenic reporter mice (TdT reporter and lineage-trace), single-cell CITE-seq, flow cytometry, differentiation assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — newly generated transgenic reporter mice with single-cell multi-omics and functional differentiation assays, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"35354960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"TdT-derived peptides presented on HLA-A*02:01 are recognized by specific TCRs that, when expressed in T cells, eliminate primary ALL cells of both T- and B-cell origin in vitro and in three mouse models of disseminated B-ALL, while sparing normal peripheral T and B cells and myeloid cells in vitro and in humanized mice. This is mechanistically explained by TdT being an intracellular, lymphoid-restricted antigen expressed highly in 80-94% of B- and T-ALLs but only transiently during normal lymphoid differentiation.\",\n      \"method\": \"TCR identification and engineering, in vitro cytotoxicity assays, three in vivo mouse models of B-ALL, humanized mice for normal cell sparing\",\n      \"journal\": \"Nature biotechnology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal in vitro and in vivo models with engineered TCR T cells, single lab but multiple experimental systems\",\n      \"pmids\": [\"34873326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Avian (chicken) TdT is expressed exclusively in the thymus (not bone marrow or bursa of Fabricius), indicating TdT plays a role in N-region addition in chicken T-cell receptor genes but not in immunoglobulin gene diversification in birds.\",\n      \"method\": \"Northern blot hybridization, RT-PCR of chicken tissues, expression of recombinant chicken TdT in bacteria with specific activity measurement\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — expression localization by Northern blot and RT-PCR combined with recombinant enzyme characterization, single lab\",\n      \"pmids\": [\"7596835\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Downregulation of TdT expression through PNA-mediated splicing modulation (targeting intron 7 splice junctions of TdT pre-mRNA) in Molt-4 cells leads to reduced TdT protein levels, increased apoptosis, and decreased cell survival, establishing TdT as functionally required for survival of TdT-expressing leukemia cells.\",\n      \"method\": \"Antisense PNA treatment, RT-PCR (splice variant analysis), Western blot (TdT protein level), apoptosis assay, cell viability assay in Molt-4 cells\",\n      \"journal\": \"Current pharmaceutical biotechnology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — sequence-specific (mismatch controls used) splicing modulation with multiple functional readouts, single lab\",\n      \"pmids\": [\"30727883\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DNTT (TdT) is a template-independent DNA polymerase that catalyzes the addition of random N-nucleotides to 3'-OH ends of DNA at V(D)J recombination junctions, generating junctional diversity in immunoglobulin and T-cell receptor genes; its activity is regulated by transcription factors (Ikaros competing with Ets activators, E47/E2A activating, c-Myc repressing), by post-translational kinase/phosphatase signaling (CK2 phosphorylation of Ikaros reduces TdT repression; PKA phosphorylation of TdT itself increases its endonuclease activity), and by direct protein inhibitors (TdIF1 blocks TdT access to DNA ends via the Pol beta-like domain, relieved by dsDNA; TReP-132 further reduces TdT activity); TdT expression is transiently induced on multipotent hematopoietic progenitors and progressively upregulated along the lymphoid trajectory, and is developmentally controlled in part by IL7Rα signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DNTT (terminal deoxynucleotidyl transferase, TdT) is a template-independent DNA polymerase that generates antigen-receptor diversity by catalyzing random N-nucleotide addition to 3'-OH DNA ends at V(D)J recombination junctions; TdT-deficient mice completely lack N regions in immunoglobulin and T-cell receptor genes, while forced expression suppresses homology-directed joining and abolishes junctional homogeneity [#0, #1, #2]. Its expression is tightly controlled along the lymphoid trajectory: it is transiently induced on multipotent progenitors and progressively upregulated toward lymphoid commitment [#16], and depends on IL7R\\u03b1 signaling in human B-cell precursors [#15]. Transcriptionally, TdT is activated by E2A/E47 [#5] and repressed by Ikaros dimers, which compete with an Ets activator at the promoter [#4]\\u2014a repression relieved by CK2 phosphorylation of Ikaros and restored by PP1 [#9]\\u2014and by a c-Myc/Max complex at the TdT initiator [#6]. Enzyme activity is further restrained by direct protein inhibitors: TdIF1 binds the Pol-beta-like region to block access to DNA ends, an inhibition relieved when TdIF1 engages double-stranded DNA [#8], and TReP-132 binds the TdT N-terminus to suppress activity [#7]. Beyond physiological diversification, TdT primes replication slippage at NPM1 to generate AML-associated 4-bp insertions [#10], and as a lymphoid-restricted antigen highly expressed in ALL it is both an immunotherapeutic target via HLA-A*02:01-presented peptides [#17] and required for leukemia cell survival [#19].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established the core physiological function of TdT: whether it is the enzyme actually responsible for junctional N-region diversity in antigen receptors, and whether its activity shapes the choice of joining pathway.\",\n      \"evidence\": \"TdT-deficient mice with direct V(D)J junction sequencing of Ig and TCR genes\",\n      \"pmids\": [\"8356451\", \"8356452\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not define how TdT is recruited to the recombination machinery\", \"Does not establish regulation of timing/level during development\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Showed that TdT levels causally determine junctional repertoire structure, demonstrating gain-of-function suppression of canonical invariant junctions in fetal thymocytes.\",\n      \"evidence\": \"CD2-promoter TdT transgenic mice with TCR gamma-delta junction analysis\",\n      \"pmids\": [\"7584135\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not address endogenous control of fetal TdT silencing\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Addressed how TdT transcription is negatively controlled at its initiation site, identifying c-Myc/Max repression of the TdT initiator.\",\n      \"evidence\": \"EMSA with supershift and co-transfection reporter assays\",\n      \"pmids\": [\"7870572\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo confirmation in developing lymphocytes\", \"Mechanism of initiator repression not resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identified a positive transcriptional regulator, showing TdT is a direct E2A target during early B-lineage commitment.\",\n      \"evidence\": \"E47 overexpression in fibroblasts with endogenous TdT transcription readout\",\n      \"pmids\": [\"8890174\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single overexpression method\", \"Direct promoter occupancy not shown\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Probed post-translational control of the enzyme itself, showing PKA phosphorylation can switch TdT toward endonuclease activity.\",\n      \"evidence\": \"In vitro phosphorylation of recombinant TdT and endonuclease assay on supercoiled plasmid\",\n      \"pmids\": [\"8667637\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single in vitro method, not validated in cells\", \"Physiological relevance of endonuclease conversion unclear\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Defined the mechanism of TdT down-regulation during thymocyte differentiation, showing Ikaros competes with an Ets activator at the promoter and couples repression to chromatin change.\",\n      \"evidence\": \"Competition binding, promoter mutagenesis in integrated reporter, chromatin accessibility, thymocyte differentiation\",\n      \"pmids\": [\"11459831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Ets activator not fully resolved\", \"Link between accessibility change and pericentromeric repositioning correlative\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified a direct protein inhibitor acting through the TdT N-terminus, expanding the set of negative regulators during V(D)J recombination.\",\n      \"evidence\": \"Yeast two-hybrid, pull-down, co-IP, in vitro activity assay, co-localization in COS7 cells\",\n      \"pmids\": [\"16371131\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance during recombination not established\", \"Structural basis of inhibition unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Resolved how TdIF1 inhibits TdT and how the inhibition is relieved, mapping a DNA-sensing switch that targets TdT to AT-rich DNA.\",\n      \"evidence\": \"Domain analysis, binding assays, in vitro TdT activity assays with dsDNA primer\",\n      \"pmids\": [\"17663723\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the TdT-TdIF1 complex\", \"In vivo consequence of the dsDNA-triggered release not shown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected kinase/phosphatase signaling to TdT transcription, showing CK2 phosphorylation of Ikaros relieves and PP1 restores TdT repression.\",\n      \"evidence\": \"Ikaros phosphomutants, CK2/PP1 inhibitors, qChIP and qRT-PCR in thymocytes and leukemia cells\",\n      \"pmids\": [\"25214003\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Does not establish CK2-Ikaros axis as the dominant control in normal development\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established a developmental signaling input controlling TdT levels in humans, linking IL7R\\u03b1 signaling to TdT expression and N-region length.\",\n      \"evidence\": \"Ig rearrangement sequencing and expression in fetal precursors and IL7R\\u03b1-deficient patient samples\",\n      \"pmids\": [\"27658954\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream effectors linking IL7R\\u03b1 to TdT transcription unknown\", \"Single study\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended TdT's mutagenic activity to leukemogenesis, modeling how N-addition primes replication slippage to generate recurrent NPM1 4-bp insertions in AML.\",\n      \"evidence\": \"Large-scale analysis of 2430 NPM1 mutations with predictive statistical modeling and pediatric/adult comparison\",\n      \"pmids\": [\"31650162\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct in vitro reconstitution of the slippage mechanism\", \"Correlative inference of TdT activity from sequence features\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Tested whether TdT is required for survival of TdT-expressing leukemia, establishing a dependency through splicing-based knockdown.\",\n      \"evidence\": \"PNA splicing modulation with apoptosis and viability readouts in Molt-4 cells\",\n      \"pmids\": [\"30727883\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line\", \"Mechanism linking TdT loss to apoptosis not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Exploited TdT as a lymphoid-restricted antigen, demonstrating engineered TCRs against TdT peptides eliminate ALL while sparing normal cells.\",\n      \"evidence\": \"TCR engineering, in vitro cytotoxicity, three B-ALL mouse models, humanized mice for normal cell sparing\",\n      \"pmids\": [\"34873326\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Restricted to HLA-A*02:01 context\", \"Long-term durability and escape not addressed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapped where TdT is first induced in hematopoiesis, identifying a multipotent progenitor subset with transient TdT and defining the lymphoid trajectory.\",\n      \"evidence\": \"TdT reporter and lineage-tracing mice with single-cell CITE-seq and differentiation assays\",\n      \"pmids\": [\"35354960\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional trigger for transient TdT induction in MPPs unknown\", \"Functional role of TdT in MPPs beyond marking lineage not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple transcriptional, signaling, and protein-inhibitor inputs are integrated to set TdT activity precisely at the recombinase, and the structural basis of its regulation, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of TdT bound to its protein inhibitors\", \"Hierarchy among E2A activation, Ikaros/c-Myc repression, and IL7R\\u03b1 control during normal development undefined\", \"Direct mechanistic link between TdT and replication slippage at NPM1 not reconstituted\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 1, 2, 3, 12]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 1, 2, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 17, 19]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 5, 6, 9]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"TdIF1\", \"TReP-132\", \"Ikaros\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}